Frédéric Brocard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Frédéric Brocard has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
Cécile Brocard
Institut de Neurosciences de la Timone, UMR 7289, Aix-Marseille Université and Centre National de la Recherche Scientifique (CNRS), Marseille, France
13 shared publicationsLaurent Vinay
Institut de Neurosciences de la Timone, UMR 7289, Aix-Marseille Université and Centre National de la Recherche Scientifique (CNRS)
13 shared publications- Rémi Bos
Aix-Marseille Université, Centre National de La Recherche Scientifique, Institut de Neurosciences de la Timone, Marseille, France
7 shared publications Sabrina Tazerart
Institut de Neurosciences de la Timone (UMR7289), Aix-Marseille Université and CNRS, Marseille, France, and
7 shared publicationsSylvie Liabeuf
Affiliation Institut de Neurosciences de la Timone, Aix-Marseille Université, CNRS, Marseille, France
7 shared publications- Laurent Vinay
Laboratoire Plasticite ´et Physio-Pathologie de la Motricite ´ UMR 6196 Centre National de la Recherche Scientifique Aix-Marseille Universite ´ F-13402 Marseille cedex 20 France
6 shared publications
Latest Publications
- Open Access
SK2/3 CHANNELS COUPLE WITH T-TYPE CA 2+ CHANNELS TO GATE SPINAL LOCOMOTOR RHYTHM GENERATION
Summary: Initiating locomotion requires central pattern generator (CPG) interneurons to transition from tonic firing to persistent sodium current (I NaP )-dependent bursting. While I NaP provides the rhythmogenic drive, the conductances gating this transition remain unclear. Here, we show that functional coupling between small-conductance calcium-activated potassium (SK2/3) channels and low-threshold T-type Ca 2+ channels, notably Cav3.2, gates locomotor rhythm generation. Pharmacological or genetic disruption of this SK-T-type axis triggers intrinsic bursting in Hb9 interneurons, a genetically identified rhythmogenic population of the locomotor CPG, and initiates fictive locomotion, whereas SK activation silences ongoing rhythmic output. Immunohistochemical co-expression of SK2, SK3 and Cav3.2 in Hb9 interneurons provides an anatomical basis for this functional coupling. Simulation-based inference further shows that, beyond this gating mechanism, burst diversity is primarily determined by the balance between I NaP and M-type potassium conductances. Together, these findings identify SK-T-type coupling as a tunable brake on CPG activation, defining a biophysical module that controls the initiation and termination of locomotor rhythmic activity, with potential relevance for rhythmogenic circuits beyond locomotion.
Open AccessSK2/3 CHANNELS COUPLE WITH T-TYPE CA 2+ CHANNELS TO GATE SPINAL LOCOMOTOR RHYTHM GENERATION
Summary: Initiating locomotion requires central pattern generator (CPG) interneurons to transition from tonic firing to persistent sodium current (I NaP )-dependent bursting. While I NaP provides the rhythmogenic drive, the conductances gating this transition remain unclear. Here, we show that functional coupling between small-conductance calcium-activated potassium (SK2/3) channels and low-threshold T-type Ca 2+ channels, notably Cav3.2, gates locomotor rhythm generation. Pharmacological or genetic disruption of this SK-T-type axis triggers intrinsic bursting in Hb9 interneurons, a genetically identified rhythmogenic population of the locomotor CPG, and initiates fictive locomotion, whereas SK activation silences ongoing rhythmic output. Immunohistochemical co-expression of SK2, SK3 and Cav3.2 in Hb9 interneurons provides an anatomical basis for this functional coupling. Simulation-based inference further shows that, beyond this gating mechanism, burst diversity is primarily determined by the balance between I NaP and M-type potassium conductances. Together, these findings identify SK-T-type coupling as a tunable brake on CPG activation, defining a biophysical module that controls the initiation and termination of locomotor rhythmic activity, with potential relevance for rhythmogenic circuits beyond locomotion.
- Open Access
- 4 February 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19
KCC2 phosphorylation dynamics relate to oligomerization during development and after spinal cord injury
Effective synaptic inhibition relies on KCC2, a K + -Cl − cotransporter that forms oligomers to extrude chloride. However, how phosphorylation regulates oligomerization remains unclear. To address this, we studied the phosphorylation of KCC2 in the lumbar spinal cord of neonatal rats by subcellular fractionation and phospho-specific western blotting across three paradigms with distinct expression profiles: developmental upregulation, spinal cord injury (SCI)-induced downregulation, and pharmacological rescue with the 5-HT 2 A/ 2 C agonist DOI. KCC2 moved from cytoplasm to membrane during development, exhibiting increased intracellular phosphorylation at serine, threonine, and tyrosine residues and decreased membrane tyrosine phosphorylation as a result of the oligomer formation. SCI caused a shift in this ratio in favor of lower oligomers, higher membrane tyrosine phosphorylation and lower intracellular threonine phosphorylation. DOI partially reversed these deficits, reinforcing oligomerization and adapting phosphorylation to a developmental profile. In sum, this study identifies tyrosine dephosphorylation at the membrane as a reliable correlate of oligomerization and offers a unified quantitative model for the regulation of KCC2 in development, after injury, and upon pharmacological rescue.
- 4 February 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19
Open AccessKCC2 phosphorylation dynamics relate to oligomerization during development and after spinal cord injury
Effective synaptic inhibition relies on KCC2, a K + -Cl − cotransporter that forms oligomers to extrude chloride. However, how phosphorylation regulates oligomerization remains unclear. To address this, we studied the phosphorylation of KCC2 in the lumbar spinal cord of neonatal rats by subcellular fractionation and phospho-specific western blotting across three paradigms with distinct expression profiles: developmental upregulation, spinal cord injury (SCI)-induced downregulation, and pharmacological rescue with the 5-HT 2 A/ 2 C agonist DOI. KCC2 moved from cytoplasm to membrane during development, exhibiting increased intracellular phosphorylation at serine, threonine, and tyrosine residues and decreased membrane tyrosine phosphorylation as a result of the oligomer formation. SCI caused a shift in this ratio in favor of lower oligomers, higher membrane tyrosine phosphorylation and lower intracellular threonine phosphorylation. DOI partially reversed these deficits, reinforcing oligomerization and adapting phosphorylation to a developmental profile. In sum, this study identifies tyrosine dephosphorylation at the membrane as a reliable correlate of oligomerization and offers a unified quantitative model for the regulation of KCC2 in development, after injury, and upon pharmacological rescue.
- Open Access
Calpains at the Crossroads of Spinal Cord Physiology, Plasticity, and Pathology
Calcium-dependent cysteine proteases, known as calpains, emerge as important regulators of spinal cord physiology, plasticity, and pathology. First characterized in the brain, they influence a wide range of processes in the spinal cord, maintaining neuronal homeostasis, shaping both synaptic and intrinsic plasticity, and modulating glial responses. When dysregulated, calpains contribute to the pathophysiology of traumatic and neurodegenerative spinal cord disorders, as well as to their associated motor and sensory complications, including spasticity and neuropathic pain. A recurring feature of these conditions is calpain-mediated proteolysis of ion channels, transporters, and cytoskeletal proteins, which promotes disinhibition and neuronal hyperexcitability. The resultant protein fragments are examined as prospective biomarkers for damage and disease progression. Meanwhile, promising strategies for neuroprotection and functional recovery in the clinic emerge as a result of innovative pharmacological and genetic approaches to modulate calpain activity. In this review, we present the current state of knowledge regarding the functions and regulation of calpains in the spinal cord and assess their translational potential as both therapeutic targets and effectors in spinal cord disorders.
Open AccessCalpains at the Crossroads of Spinal Cord Physiology, Plasticity, and Pathology
Calcium-dependent cysteine proteases, known as calpains, emerge as important regulators of spinal cord physiology, plasticity, and pathology. First characterized in the brain, they influence a wide range of processes in the spinal cord, maintaining neuronal homeostasis, shaping both synaptic and intrinsic plasticity, and modulating glial responses. When dysregulated, calpains contribute to the pathophysiology of traumatic and neurodegenerative spinal cord disorders, as well as to their associated motor and sensory complications, including spasticity and neuropathic pain. A recurring feature of these conditions is calpain-mediated proteolysis of ion channels, transporters, and cytoskeletal proteins, which promotes disinhibition and neuronal hyperexcitability. The resultant protein fragments are examined as prospective biomarkers for damage and disease progression. Meanwhile, promising strategies for neuroprotection and functional recovery in the clinic emerge as a result of innovative pharmacological and genetic approaches to modulate calpain activity. In this review, we present the current state of knowledge regarding the functions and regulation of calpains in the spinal cord and assess their translational potential as both therapeutic targets and effectors in spinal cord disorders.
- Open Access
Ionic Mechanisms Underlying Bistability in Spinal Motoneurons: Insights from a Computational Model
Spinal motoneurons are the final output of spinal circuits that engage skeletal muscles to generate motor behaviors. Many motoneurons exhibit bistable behavior, alternating between a quiescent resting state and a self-sustained firing mode, classically attributed to plateau potentials driven by persistent inward currents. This intrinsic property is important for normal movement control, but can become dysregulated, causing motor function deficits, like spasticity. Here we use a conductance-based single-compartment model, together with mouse spinal slice recordings,to investigate the ionic interactions underlying motoneuron bistability. We show that synergistic interactions among high-voltage-activated L-type Ca 2+ current ( I CaL ), calcium-induced calcium release (CICR) and the Ca 2+ -activated non-specific cation current ( I CAN ) constitute a minimal mechanistic core that produces plateau potentials and bistable firing. Within this framework, the persistent sodium current ( I NaP ) promotes plateau generation, in contrast to the Ca 2+ -dependent K + current ( I KCa ) which opposes it. These results delineate ionic dependencies at the level of interactions rather than spatial localisation and provide a tractable basis for interpreting altered motoneuron excitability in disease. Key Points: We investigated how spinal motoneurons, critical for skeletal muscle control, exhibit bistability, switching between quiet and self-sustained firing. This property stabilizes motor functions like postural control, and its dysregulation contributes to disorders such as spasticity. Using a single-compartment computational model and mouse spinal slice recordings, we explored the ionic interactions driving bistability. Our findings reveal that a calcium-activated cation non-specific current and calcium-induced calcium release form a core mechanism supporting the plateau depolarization essential for bistable firing. Within this framework, the persistent sodium current facilitates plateau generation, while the calcium-dependent potassium current counteracts it. Pharmacological manipulations in slices yielded results consistent with these current roles. Our study delineates the ionic dependencies of motoneuron bistability based on interactions, not spatial location. This offers a concise framework for interpreting excitability changes observed in normal conditions and following spinal cord injury, providing valuable insights into motor function and neurological disorders.
Open AccessIonic Mechanisms Underlying Bistability in Spinal Motoneurons: Insights from a Computational Model
Spinal motoneurons are the final output of spinal circuits that engage skeletal muscles to generate motor behaviors. Many motoneurons exhibit bistable behavior, alternating between a quiescent resting state and a self-sustained firing mode, classically attributed to plateau potentials driven by persistent inward currents. This intrinsic property is important for normal movement control, but can become dysregulated, causing motor function deficits, like spasticity. Here we use a conductance-based single-compartment model, together with mouse spinal slice recordings,to investigate the ionic interactions underlying motoneuron bistability. We show that synergistic interactions among high-voltage-activated L-type Ca 2+ current ( I CaL ), calcium-induced calcium release (CICR) and the Ca 2+ -activated non-specific cation current ( I CAN ) constitute a minimal mechanistic core that produces plateau potentials and bistable firing. Within this framework, the persistent sodium current ( I NaP ) promotes plateau generation, in contrast to the Ca 2+ -dependent K + current ( I KCa ) which opposes it. These results delineate ionic dependencies at the level of interactions rather than spatial localisation and provide a tractable basis for interpreting altered motoneuron excitability in disease. Key Points: We investigated how spinal motoneurons, critical for skeletal muscle control, exhibit bistability, switching between quiet and self-sustained firing. This property stabilizes motor functions like postural control, and its dysregulation contributes to disorders such as spasticity. Using a single-compartment computational model and mouse spinal slice recordings, we explored the ionic interactions driving bistability. Our findings reveal that a calcium-activated cation non-specific current and calcium-induced calcium release form a core mechanism supporting the plateau depolarization essential for bistable firing. Within this framework, the persistent sodium current facilitates plateau generation, while the calcium-dependent potassium current counteracts it. Pharmacological manipulations in slices yielded results consistent with these current roles. Our study delineates the ionic dependencies of motoneuron bistability based on interactions, not spatial location. This offers a concise framework for interpreting excitability changes observed in normal conditions and following spinal cord injury, providing valuable insights into motor function and neurological disorders.
- Open Access
- 21 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0319635
The SpasT-SCI-T trial protocol: Investigating calpain-mediated sodium channel fragments as biomarkers for traumatic CNS injuries and spasticity prediction
Spinal cord injury and traumatic brain injury are major causes of long-term disability and are often complicated by spasticity, a motor disorder characterized by increased muscle tone and exaggerated reflexes that significantly impair quality of life. Current diagnostic methods lack the sensitivity needed to accurately predict the severity of injury or the onset and progression of spasticity. Trauma-induced calcium dysregulation activates calpains, a family of proteases that cleave sodium channels, disrupting their inactivation and increasing persistent sodium currents. This cascade drives the overexcitability of motoneurons, contributing to the development of spasticity. Consequently, sodium channel fragments have emerged as promising biomarkers that link injury mechanisms to clinical outcomes. The present SpasT-SCI-T clinical trial protocol aims to evaluate sodium channel fragments as blood biomarkers for assessing the severity of spinal cord and traumatic brain injuries, as well as their potential to predict clinical outcomes, including the development of spasticity. This prospective, multicenter, case-control and cohort study involves 40 participants: 20 individuals with spinal cord injury, 10 individuals with traumatic brain injury, and 10 healthy controls. Blood samples are collected within six hours of injury and at follow-up points over six months. Clinical outcomes, including spasticity (assessed using the Modified Ashworth Scale), neurological recovery (measured by the American Spinal Injury Association Impairment Scale and Glasgow Coma Scale), and quality of life (evaluated using the Short Form-36 Health Survey), are analyzed in correlation with biomarker levels. We anticipate that calpain-mediated sodium channel fragments will transform the management of central nervous system injuries by enabling early diagnosis, improving prognostic accuracy, and guiding personalized therapeutic strategies. The clinical trial is registered on ClinicalTrials.gov (NCT06532760, January 10, 2024), with Assistance Publique–Hôpitaux de Marseille as the sponsor.
- 21 May 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (5) , e0319635
Open AccessThe SpasT-SCI-T trial protocol: Investigating calpain-mediated sodium channel fragments as biomarkers for traumatic CNS injuries and spasticity prediction
Spinal cord injury and traumatic brain injury are major causes of long-term disability and are often complicated by spasticity, a motor disorder characterized by increased muscle tone and exaggerated reflexes that significantly impair quality of life. Current diagnostic methods lack the sensitivity needed to accurately predict the severity of injury or the onset and progression of spasticity. Trauma-induced calcium dysregulation activates calpains, a family of proteases that cleave sodium channels, disrupting their inactivation and increasing persistent sodium currents. This cascade drives the overexcitability of motoneurons, contributing to the development of spasticity. Consequently, sodium channel fragments have emerged as promising biomarkers that link injury mechanisms to clinical outcomes. The present SpasT-SCI-T clinical trial protocol aims to evaluate sodium channel fragments as blood biomarkers for assessing the severity of spinal cord and traumatic brain injuries, as well as their potential to predict clinical outcomes, including the development of spasticity. This prospective, multicenter, case-control and cohort study involves 40 participants: 20 individuals with spinal cord injury, 10 individuals with traumatic brain injury, and 10 healthy controls. Blood samples are collected within six hours of injury and at follow-up points over six months. Clinical outcomes, including spasticity (assessed using the Modified Ashworth Scale), neurological recovery (measured by the American Spinal Injury Association Impairment Scale and Glasgow Coma Scale), and quality of life (evaluated using the Short Form-36 Health Survey), are analyzed in correlation with biomarker levels. We anticipate that calpain-mediated sodium channel fragments will transform the management of central nervous system injuries by enabling early diagnosis, improving prognostic accuracy, and guiding personalized therapeutic strategies. The clinical trial is registered on ClinicalTrials.gov (NCT06532760, January 10, 2024), with Assistance Publique–Hôpitaux de Marseille as the sponsor.
- Open Access
Calpain-mediated sodium channel fragments in the monocentric SpasT-SCI-T trial: Biomarkers for central nervous system injuries and spasticity prediction
Spinal cord injury and traumatic brain injury are major causes of long-term disability and are often complicated by spasticity, a motor disorder characterized by increased muscle tone and exaggerated reflexes that significantly impair quality of life. Current diagnostic methods lack the sensitivity needed to accurately predict the severity of injury or the onset and progression of spasticity. Trauma-induced calcium dysregulation activates calpains, a family of proteases that cleave sodium channels, disrupting their inactivation and increasing persistent sodium currents. This cascade drives the overexcitability of motoneurons, contributing to the development of spasticity. Consequently, sodium channel fragments have emerged as promising biomarkers that link injury mechanisms to clinical outcomes. The present SpasT-SCI-T clinical trial protocol aims to evaluate sodium channel fragments as blood biomarkers for assessing the severity of spinal cord and traumatic brain injuries, as well as their potential to predict clinical outcomes, including the development of spasticity. This prospective, multicenter, case-control and cohort study involves 40 participants: 20 individuals with spinal cord injury, 10 individuals with traumatic brain injury, and 10 healthy controls. Blood samples are collected within six hours of injury and at follow-up points over six months. Clinical outcomes, including spasticity (assessed using the Modified Ashworth Scale), neurological recovery (measured by the American Spinal Injury Association Impairment Scale and Glasgow Coma Scale), and quality of life (evaluated using the Short Form-36 Health Survey), are analyzed in correlation with biomarker levels. We anticipate that calpain-mediated sodium channel fragments will transform the management of central nervous system injuries by enabling early diagnosis, improving prognostic accuracy, and guiding personalized therapeutic strategies. The clinical trial is registered on ClinicalTrials.gov ( NCT06532760 , January 10, 2024), with Assistance Publique–Hôpitaux de Marseille as the sponsor.
Open AccessCalpain-mediated sodium channel fragments in the monocentric SpasT-SCI-T trial: Biomarkers for central nervous system injuries and spasticity prediction
Spinal cord injury and traumatic brain injury are major causes of long-term disability and are often complicated by spasticity, a motor disorder characterized by increased muscle tone and exaggerated reflexes that significantly impair quality of life. Current diagnostic methods lack the sensitivity needed to accurately predict the severity of injury or the onset and progression of spasticity. Trauma-induced calcium dysregulation activates calpains, a family of proteases that cleave sodium channels, disrupting their inactivation and increasing persistent sodium currents. This cascade drives the overexcitability of motoneurons, contributing to the development of spasticity. Consequently, sodium channel fragments have emerged as promising biomarkers that link injury mechanisms to clinical outcomes. The present SpasT-SCI-T clinical trial protocol aims to evaluate sodium channel fragments as blood biomarkers for assessing the severity of spinal cord and traumatic brain injuries, as well as their potential to predict clinical outcomes, including the development of spasticity. This prospective, multicenter, case-control and cohort study involves 40 participants: 20 individuals with spinal cord injury, 10 individuals with traumatic brain injury, and 10 healthy controls. Blood samples are collected within six hours of injury and at follow-up points over six months. Clinical outcomes, including spasticity (assessed using the Modified Ashworth Scale), neurological recovery (measured by the American Spinal Injury Association Impairment Scale and Glasgow Coma Scale), and quality of life (evaluated using the Short Form-36 Health Survey), are analyzed in correlation with biomarker levels. We anticipate that calpain-mediated sodium channel fragments will transform the management of central nervous system injuries by enabling early diagnosis, improving prognostic accuracy, and guiding personalized therapeutic strategies. The clinical trial is registered on ClinicalTrials.gov ( NCT06532760 , January 10, 2024), with Assistance Publique–Hôpitaux de Marseille as the sponsor.
- Open Access
- 29 January 2024
- Published by Elsevier in Molecular Therapy
- Vol. 32 (4) , 1096-1109
Knockdown of calpain1 in lumbar motoneurons reduces spasticity after spinal cord injury in adult rats
- 29 January 2024
- Published by Elsevier in Molecular Therapy
- Vol. 32 (4) , 1096-1109
Open AccessKnockdown of calpain1 in lumbar motoneurons reduces spasticity after spinal cord injury in adult rats
- Open Access
A size principle for bistability in mouse spinal motoneurons
Bistability in spinal motoneurons supports tonic spike activity in the absence of excitatory drive. Earlier work in adult preparations suggested that smaller motoneurons innervating slow antigravity muscle fibers are more likely to generate bistability for postural maintenance. However, whether large motoneurons innervating fast-fatigable muscle fibers display bistability related to postural tone is still controversial. To address this, we examined the relationship between soma size and bistability in lumbar ventrolateral α-motoneurons of ChAT-GFP and Hb9-GFP mice across different developmental stages: neonatal (P2-P7), young (P7-P14) and mature (P21-P25). We found that as neuron size increases, the prevalence of bistability rises. Smaller α-motoneurons lack bistability, while larger fast α-motoneurons (MMP-9 + /Hb9 + ) with a soma area ≥ 400µm 2 exhibit significantly higher bistability. Ionic currents associated with bistability, including the persistent Nav1.6 current, thermosensitive Trpm5 Ca 2+ -activated Na + current and the slowly inactivating Kv1.2 current, also scale with cell size. Serotonin evokes full bistability in large motoneurons with partial bistable properties, but not in small motoneurons. Our study provides important insights into the neural mechanisms underlying bistability and how motoneuron size dictates this process. New and Noteworthy: Bistability is not a common feature of all mouse spinal motoneurons. It is absent in small, slow motoneurons but present in most large, fast motoneurons. This difference results from differential expression of ionic currents that enable bistability, which are highly expressed in large motoneurons but small or absent in small motoneurons. These results support a possible role for fast motoneurons in maintenance of tonic posture in addition to their known roles in fast movements.
Open AccessA size principle for bistability in mouse spinal motoneurons
Bistability in spinal motoneurons supports tonic spike activity in the absence of excitatory drive. Earlier work in adult preparations suggested that smaller motoneurons innervating slow antigravity muscle fibers are more likely to generate bistability for postural maintenance. However, whether large motoneurons innervating fast-fatigable muscle fibers display bistability related to postural tone is still controversial. To address this, we examined the relationship between soma size and bistability in lumbar ventrolateral α-motoneurons of ChAT-GFP and Hb9-GFP mice across different developmental stages: neonatal (P2-P7), young (P7-P14) and mature (P21-P25). We found that as neuron size increases, the prevalence of bistability rises. Smaller α-motoneurons lack bistability, while larger fast α-motoneurons (MMP-9 + /Hb9 + ) with a soma area ≥ 400µm 2 exhibit significantly higher bistability. Ionic currents associated with bistability, including the persistent Nav1.6 current, thermosensitive Trpm5 Ca 2+ -activated Na + current and the slowly inactivating Kv1.2 current, also scale with cell size. Serotonin evokes full bistability in large motoneurons with partial bistable properties, but not in small motoneurons. Our study provides important insights into the neural mechanisms underlying bistability and how motoneuron size dictates this process. New and Noteworthy: Bistability is not a common feature of all mouse spinal motoneurons. It is absent in small, slow motoneurons but present in most large, fast motoneurons. This difference results from differential expression of ionic currents that enable bistability, which are highly expressed in large motoneurons but small or absent in small motoneurons. These results support a possible role for fast motoneurons in maintenance of tonic posture in addition to their known roles in fast movements.
- Open Access
- 3 September 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (9) , 113085
Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics
- 3 September 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (9) , 113085
Open AccessPersistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics
- Open Access
Persistent Nav1.6 current drives spinal locomotor functions through nonlinear dynamics
Summary: Persistent sodium current ( I NaP ) in the spinal locomotor network promotes two distinct nonlinear firing patterns: a self-sustained spiking triggered by a brief excitation in bistable motoneurons and bursting oscillations in interneurons of the central pattern generator (CPG). Here, we identified the NaV channels responsible for I NaP and their role in motor behaviors. We report the axonal Nav1.6 as the main molecular player for I NaP in lumbar motoneurons. The motoneuronal inhibition of Nav1.6 , but not of Nav1.1 , impairs I NaP , bistability, postural tone and locomotor performance. In interneurons of the CPG region, Nav1.6 with Nav1.1 equally mediate I NaP and the inhibition of both channels is required to abolish oscillatory bursting activities and the locomotor rhythm. Overall, Nav1.6 plays a significant role both in posture and locomotion by governing I NaP -dependent bistability in motoneurons and working in tandem with Nav1.1 to provide I NaP -dependent rhythmogenic properties of the CPG.
Open AccessPersistent Nav1.6 current drives spinal locomotor functions through nonlinear dynamics
Summary: Persistent sodium current ( I NaP ) in the spinal locomotor network promotes two distinct nonlinear firing patterns: a self-sustained spiking triggered by a brief excitation in bistable motoneurons and bursting oscillations in interneurons of the central pattern generator (CPG). Here, we identified the NaV channels responsible for I NaP and their role in motor behaviors. We report the axonal Nav1.6 as the main molecular player for I NaP in lumbar motoneurons. The motoneuronal inhibition of Nav1.6 , but not of Nav1.1 , impairs I NaP , bistability, postural tone and locomotor performance. In interneurons of the CPG region, Nav1.6 with Nav1.1 equally mediate I NaP and the inhibition of both channels is required to abolish oscillatory bursting activities and the locomotor rhythm. Overall, Nav1.6 plays a significant role both in posture and locomotion by governing I NaP -dependent bistability in motoneurons and working in tandem with Nav1.1 to provide I NaP -dependent rhythmogenic properties of the CPG.